ArticleHeliyon2024
Advancing thyroid care: An accurate trustworthy diagnostics system with interpretable AI and hybrid machine learning techniques.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Interpretable LightGBM model with SHAP analysis predicts non-excellent response to initial radioiodine therapy in differentiated thyroid carcinoma.Journal of applied clinical medical physics · 2026Article
- A reliable and explainable deep learning framework for clinical-grade endocrine disorder risk prediction and decision support.Frontiers in artificial intelligence · 2026Article
- A comparative study on advanced predictive modeling of thyroid cancer recurrence using multi algorithmic machine learning frameworks.Scientific reports · 2025Article
- Deep learning based thyroid prediction with opposition learning based red panda optimization feature selection.Scientific reports · 2025Article
- An explainable multi-objective hybrid machine learning model for reducing heart failure mortality.PeerJ. Computer science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The worldwide prevalence of thyroid disease is on the rise, representing a chronic condition that significantly impacts global mortality rates. Machine learning (ML) approaches have demonstrated potential superiority in mitigating the occurrence of this disease by facilitating early detection and treatment. However, there is a growing demand among stakeholders and patients for reliable and credible explanations of the generated predictions in sensitive medical domains. Hence, we propose an interpretable thyroid classification model to illustrate outcome explanations and investigate the contribution of predictive features by utilizing explainable AI. Two real-time thyroid datasets underwent various preprocessing approaches, addressing data imbalance issues using the Synthetic Minority Over-sampling Technique with Edited Nearest Neighbors (SMOTE-ENN). Subsequently, two hybrid classifiers, namely RDKVT and RDKST, were introduced to train the processed and selected features from Univariate and Information Gain feature selection techniques. Following the training phase, the Shapley Additive Explanation (SHAP) was applied to identify the influential characteristics and corresponding values contributing to the outcomes. The conducted experiments ultimately concluded that the presented RDKST classifier achieved the highest performance, demonstrating an accuracy of 98.98 % when trained on Information Gain selected features. Notably, the features T3 (triiodothyronine), TT4 (total thyroxine), TSH (thyroid-stimulating hormone), FTI (free thyroxine index), and T3_measured significantly influenced the generated outcomes. By balancing classification accuracy and outcome explanation ability, this study aims to enhance the clinical decision-making process and improve patient care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.